Anti-rheumatic efficacy of naproxen
Philip, J.; Joseph, P.P.; Das, K.V.
Journal of the Association of Physicians of India 30(9): 593-596
1982
ISSN/ISBN: 0004-5772 PMID: 6764215 Document Number: 187888
Document emailed within 1 workday
Related Documents
Marzo, A.; Ripamonti, M.; Benatti, P.; Marzo, P.; Wool, C.; Cerutti, R.; Reiner, V. 1997: Absorption and distribution of naproxen in rats orally treated with naproxen betainate sodium salt monohydrate. Comparison with naproxen Arzneimittel-Forschung 47(4): 381-384Biehl, G. 1980: Therapy of degenerative joint diseases of a rheumatic nature. Effectiveness of naproxen at a daily dosage of 500 mg Fortschritte der Medizin 98(40): 1568-1570
Simon, B.; Leucht, U.; Amon, I.; Brandau, J.; Müller, P. 1993: Nizatidine in therapy and prevention of non-steroidal anti-rheumatic drug-induced ulcers in rheumatic patients Zeitschrift für Gastroenterologie 31(6): 395-400
Boussina, I.; Vischer, T.L. 1987: Efficacy and tolerance of naproxen versus pirprofen in the treatment of patients with osteoarthritis Pharmatherapeutica 5(1): 16-20
Deal, C.L.; Moskowitz, R.W. 1986: Efficacy of diflunisal versus naproxen in osteoarthritis of the knee: an open study Clinical Therapeutics 9(Suppl): 1-14
Ristić, A.; Stern, P. 1974: Anti-inflammatory and anti-rheumatic effect of Fojnica's mineral water Reumatizam 21(6): 231-233
Tsvetkova, E.S.; Sigidin, I.A. 1981: Comparative efficacy of voltaren and naproxen in rheumatoid arthritis (double-blind trial) Terapevticheskii Arkhiv 53(7): 111-114
De Arcangelis, A. 1971: On the use in anti-rheumatic therapy of a new non-steroid anti-inflammatory agent: glucosamide of monohydrated (N-p-chloro-benzoyl-2-methyl-5-methoxy)-indol-3-acetic acid La Clinica Terapeutica 59(3): 229-239
López-Fiesco, A.; Luján, M.; Alvarez, J.M.; Zamora Lopez, G.; Martínez, E.L. 1992: Evaluation of the analgesic efficacy of a combination of naproxen and paracetamol versus dipyrone on the tourniquet test in healthy volunteers Proceedings of the Western Pharmacology Society 35: 207-210
Kriegel, W.; Korff, K.J.; Ehrlich, J.C.; Lehnhardt, K.; Macciocchi, A.; Moresino, C.; Pawlowski, C. 2001: Double-blind study comparing the long-term efficacy of the COX-2 inhibitor nimesulide and naproxen in patients with osteoarthritis International Journal of Clinical Practice 55(8): 510-514
Butrón, F.; Galicia, A.; Zamora, G.; Martinez-Zurita, F. 1994: Single blind study to evaluate the efficacy and safety of naproxen gel compared with diclophenac emulgel in the treatment of soft tissue injuries Proceedings of the Western Pharmacology Society 37: 153-156
Forest, G. 1984: Effect of anti-HLA-A1 and anti-PLA1 antibodies on the efficacy of platelet transfusion L'Union Medicale du Canada 113(7): 607-609
Takeuchi, Y. 2012: Anti-osteoporosis drugs : their characteristics and evidence for anti-fracture efficacy Clinical Calcium 22(6): 897-903
Abruzzo, J.L. 1978: Newer anti-rheumatic drugs Annals of Internal Medicine 89(1): 131-133
Brooks, P.M.; Bell, M.A.; Mason, D.I.; Buchanan, W.W. 1977: Interactions of anti-rheumatic drugs Agents and Actions. Supplements 1977(1): 85-95
Takatsu, T.; Kino, M.; Tsujimoto, G.; Kaku, K.; Sonotani, N.; Suwa, M.; Morita, H.; Hirota, Y.; Tsutsumi, J.; Kubo, S.; Kawamura, K. 1979: Recurrence of rheumatic fever and valvular diseases--etiology of rheumatic fever, rheumatic carditis and recurrent rheumatic fever Nihon Rinsho. Japanese Journal of Clinical Medicine 37(8): 3082-3102
Gathirwa, J.W.; Rukunga, G.M.; Njagi, E.N.M.; Omar, S.A.; Mwitari, P.G.; Guantai, A.N.; Tolo, F.M.; Kimani, C.W.; Muthaura, C.N.; Kirira, P.G.; Ndunda, T.N.; Amalemba, G.; Mungai, G.M.; Ndiege, I.O. 2008: The in vitro anti-plasmodial and in vivo anti-malarial efficacy of combinations of some medicinal plants used traditionally for treatment of malaria by the Meru community in Kenya Journal of Ethnopharmacology 115(2): 223-231
Reiff, A.; Lovell, D.J.; Adelsberg, J.Van.; Kiss, M.H.B.; Goodman, S.; Zavaler, M.Ferrandiz.; Chen, P-Yun.; Bolognese, J.A.; Cavanaugh, P.; Reicin, A.S.; Giannini, E.H. 2006: Evaluation of the comparative efficacy and tolerability of rofecoxib and naproxen in children and adolescents with juvenile rheumatoid arthritis: a 12-week randomized controlled clinical trial with a 52-week open-label extension Journal of Rheumatology 33(5): 985-995
Cossio, P.M.; Kreutzer, E. 1973: Anti-myocardium factors in rheumatic fever Archivos del Instituto de Cardiologia de Mexico 42(6): 880-886
Roe, R.L. 1975: The anti-inflammatory agents used in rheumatic disorders Primary Care 2(2): 259-273